journal article·2022-08

Spontaneously Restoring Specific Bioaffinity of RGD in Linear RGD-containing Peptides by Conjugation with Zwitterionic Dendrimers

Liangbo Xu, Nan Xu, Longgang Wang, Haofeng Qian, Yihan Li, Mandi Fang, Ziyin Xiang, Weifeng Lin, Fanxing Zhang, Qing Shao, Matthew T. Bernards, Yao Shi, Yi He, Shengfu Chen

Acta Biomaterialia· Volume 148
Publisher page

Abstract

Peptides are more versatile than small molecule drugs, but their specific bioaffinities are usually lower than their original native proteins because of the loss of preferred conformations. To overcome this key obstacle, we demonstrated a hydrogen bond-induced conformational constraint method to enhance the specific bioaffinities of peptides to achieve a high success rate by using linear RGD-containing peptides as a model of bioactive peptides. By performing molecular simulation, we found that the chemically immobilized linear CRGDS via cysteine (C) at the N-terminus on zwitterionic PAMAM G-5 can not only spontaneously restore the natural conformation of the RGD segment through the assistance of the dynamic hydrogen bond from serine (S) at the C-terminus of the peptide, but it can also narrow the distribution of all possible conformations. Consequently, the conjugates showed comparable or even better high affinity than native proteins without the use of conventional, labor-intensive, synthesis-based structure search methods to construct a binding conformation. In addition, the conjugates showed globular protein-like characteristics chemically, physically, and physiologically. They exhibited not only high efficacy and biosafety both in vitro and in vivo, but they also showed extremely high thermostability even upon boiling in a solution. This approach offers great design flexibility for reviving functional peptides without impairing their high specific affinity for their targets. STATEMENT OF SIGNIFICANCE: In this work, we developed a swift approach to spontaneously restore the natural conformation of a linear peptide from a nature protein and thus enhance its specific bioaffinity instead of constructing a binding conformation by the labor-intensive, synthesis-based structure search method. In details, our new approach involves dynamically constraining the linear peptide on a zwitterionic PAMAM G-5 surface by a combination of chemical bonding at one terminus and dynamic hydrogen bonding at the other terminus of the linear peptide. The zwitterionic background offers abundant interaction sites for hydrogen bonding as well as resistance to nonspecific interactions. This approach fully restores the specific bioaffinity of RGD segments on a zwitterionic PAMAM G-5 through only one conjugation point at the C-terminus of the peptide. Moreover, the bioaffinity of all three types of RGD-containing peptides is successfully restored, which indicates the high rate of success of this approach in affinity restoring.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Chemical Synthesis and Analysis · RNA Interference and Gene Delivery · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Protein interaction networks revealed by proteome coevolution10.1126/science.aaw6718 ↗
2. Competing protein-protein interactions regulate binding of Hsp27 to its client protein tau10.1038/s41467-018-07012-4 ↗
3. Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics10.1038/s41388-019-1056-3 ↗
4. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge10.1038/nrd.2016.29 ↗
5. The druggable genome10.1038/nrd892 ↗
6. Peptide-based nanoprobes for molecular imaging and disease diagnostics10.1039/C7CS00793K ↗
7. Synthesis, structure and activity of artificial, rationally designed catalytic polypeptides10.1038/365530a0 ↗
8. High-Affinity Self-Reactive Human-Antibodies by Design and Selection - Targeting the Integrin Ligand-Binding Site10.1073/pnas.90.21.10003 ↗
9. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge10.1038/nrd.2016.29 ↗
10. Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer10.1126/sciadv.aax2277 ↗
11. Conformational selection or induced fit: A flux description of reaction mechanism10.1073/pnas.0907195106 ↗
12. The role of dynamic conformational ensembles in biomolecular recognition10.1038/nchembio.232 ↗
13. Application of a Theory of Enzyme Specificity to Protein Synthesis10.1073/pnas.44.2.98 ↗
14. The Key-Lock Theory and the Induced Fit Theory10.1002/anie.199423751 ↗
15. Decoding nonspecific interactions from nature10.1039/c2sc21135a ↗
16. Molecular Imaging of Breast Cancer: Role of RGD Peptides10.2174/1389557515666150909144606 ↗
17. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling10.1038/sj.onc.1210429 ↗
18. Every step of the way: integrins in cancer progression and metastasis10.1038/s41568-018-0038-z ↗
19. Exploring the Role of RGD-Recognizing Integrins in Cancer10.3390/cancers9090116 ↗
20. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro10.1021/jm00114a022 ↗
21. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers10.1016/j.softx.2015.06.001 ↗
22. Improved side-chain torsion potentials for the Amber ff99SB protein force field10.1002/prot.22711 ↗
23. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules10.1021/ja00124a002 ↗
24. Dendrimer building toolkit: Model building and characterization of various dendrimer architectures10.1002/jcc.23031 ↗
25. Case · 2016
26. Antechamber: an accessory software package for molecular mechanical calculations
27. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model
28. Lipid14: the amber lipid force field10.1021/ct4010307 ↗
29. Self-consistent molecular orbital methods. XXIII. A polarization-type basis set for second-row elements10.1063/1.444267 ↗
30. 6-31G* basis set for third-row atoms10.1002/jcc.1058 ↗
31. Frisch · 2016
32. Pymol: An open-source molecular graphics tool
33. ACPYPE-Antechamber python parser interface10.1186/1756-0500-5-367 ↗
34. Canonical sampling through velocity rescaling10.1063/1.2408420 ↗
35. Polymorphic transitions in single crystals: A new molecular dynamics method
36. LINCS: a linear constraint solver for molecular simulations10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H ↗
37. A smooth particle mesh Ewald method10.1063/1.470117 ↗
38. The free energy landscape for beta hairpin folding in explicit water10.1073/pnas.201543998 ↗
39. Reducing the cytotoxity of poly(amidoamine) dendrimers by modification of a single layer of carboxybetaine10.1021/la400623s ↗
40. Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity10.1021/nn2013904 ↗
41. Cytotoxicity, Hemolysis, and Acute in Vivo Toxicity of Dendrimers Based on Melamine, Candidate Vehicles for Drug Delivery10.1021/ja048548j ↗
42. Investigation of the Hydration of Nonfouling Material Poly(ethylene glycol) by Low-Field Nuclear Magnetic Resonance10.1021/la203827h ↗
43. Investigation of the Hydration of Nonfouling Material Poly(sulfobetaine methacrylate) by Low-Field Nuclear Magnetic Resonance10.1021/la300394c ↗
44. Crystal structure of the extracellular segment of integrin alpha V beta 3 in complex with an Arg-Gly-Asp ligand10.1126/science.1069040 ↗
45. Ultra-low fouling peptide surfaces derived from natural amino acids10.1016/j.biomaterials.2009.07.001 ↗
46. Beware of phosphate: evidence of specific dendrimer-phosphate interactions10.1039/C7CP00875A ↗
47. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 ↗
48. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro10.1023/B:AGEN.0000011801.98187.f2 ↗
49. Integrins in angiogenesis: multitalented molecules in a balancing act10.1007/s00441-003-0774-5 ↗
50. Integrins and cancer10.1016/S0955-0674(96)80115-3 ↗
51. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors10.1038/nm.1941 ↗
52. Development of a Protein Mimic with Peptide Ligands to Enhance Specific Sensing and Targeting by the Zwitterionic Surface Engineering of Poly(amido amine) Dendrimers10.1002/admi.201300059 ↗